The 2022 American Association for Cancer Research (AACR) Annual Meeting represents the first major in-person oncology industry event in more than years and George Clinical invites you to engage our scientific leaders, clinical operations experts and business development team to schedule formal briefings or informal meetings at our exhibit (#1052). Oncologists Dr. Ari VanderWalde, a long-standing George Clinical scientific leader, and Professor David Thomas from partner organization OMICO will both be in attendance
AACR runs from April 8–13 in New Orleans, Louisiana with exhibition hours daily from April 10–13. The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
Would you like to schedule a meeting at AACR? Contact Matthew Reabold, Head, US/EU Sales and Business Development, [email protected] to set one up.
Professor Thomas’ research focus is on the application of genomic technologies to the understanding and management of cancer. He is the inaugural Director, Centre for Molecular Oncology, University of New South Wales; Head of the Genomic Cancer Medicine Laboratory, Garvan Institute of Medical Research; and CEO of Omico. He founded the Australasian Sarcoma Study Group and established Australia’s leading adolescent and young adult cancer unit at the Peter MacCallum Cancer Centre. Professor Thomas leads the International Sarcoma Kindred Study and led the first international study of denosumab in Giant Cell Tumor of bone, leading to FDA and TGA approval.
Dr. VanderWalde specializes in melanoma and is experienced in genomic tumor assessment, public health, tumor immunotherapy, medical ethics and precision oncology. He is the Global Head of Clinical Research at Caris Life Sciences and works as Research Faculty at West Cancer Center where he served as the Director of Research from 2014 to 2021. He is also Professor in the Division of Epidemiology at the University of Memphis School of Public Health. Dr. VanderWalde has extensive experience in clinical research, including the design and conduct of clinical trials, results reporting, regulatory filing and interactions between investigators and the pharmaceutical industry.
Ernest N. Morial Convention Center
900 Convention Center Blvd
New Orleans, LA
Meet with George Clinical! Contact us to schedule a time now.
